PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
Position in DMAC — DiaMedica Therapeutics Inc.
CIK 1047859
DALLAS, TX
Position in DMAC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,923,750
-$1,041,250 QoQ
Shares Held
875,000
0.0% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
8.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE holds $5,923,750 across 1 Biotechnology name. DMAC ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMAC |
DiaMedica Therapeutics Inc.
This page
|
875,000 | $5,923,750 |
All Filings in DMAC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,923,750 | 875,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,965,000 | 875,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,011,250 | 875,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,535,000 | 650,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,274,000 | 600,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,795,277 | 514,784 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,022,152 | 482,614 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,423,711 | 482,614 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,385,000 | 500,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,420,000 | 500,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,212,600 | 470,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,404,000 | 325,000 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||